Gambia Children Deaths

India will take "appropriate action" after completing an investigation into a complaint that a drug regulator helped switch samples of cough syrup linked to the death of children in Gambia in return for a bribe, two officials said on Wednesday.

Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or

Cough syrup from a Haryana-based firm that allegedly caused deaths of children in Gambia, has passed all tests, sources in Union Health Ministry told NDTV today.

A joint probe by the Centers for Disease Control and Prevention (CDC) of the US and the Gambian health authorities has suggested a strong link between the death of many children in Gambia and the consumption of made-in-India cough syrups that were al

Two pharmaceutical company executives have been sentenced to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia, reported Reuters.

Citing "unacceptable levels" of toxins in the products, the WHO is seeking information about the raw materials used by six manufacturers in India and Indonesia

The Centre today said it is in touch with Uzbekistan after it alleged 18 children in the country died after taking an Indian-made cough syrup. An investigation is in progress and the manufacturing of the cough syrup has been stopped.

Uzbekistan has claimed that at least 18 children in the country have died after allegedly taking an India-manufactured cough syrup.

Maiden Pharmaceuticals Ltd will seek clearance to re-open its factory after agovernment laboratory found nothing wrong in samples taken from syrups that the World Health Organisation (WHO) had suspected of being linked to children' deaths in Gambia

The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.

Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.

Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.

The committee to examine reports linking deaths of 66 children in The Gambia to four made-in-India cough syrups has observed the information shared by the World Health Organization is inadequate to determine aetiology.

Indonesia on Saturday banned ingredients linked to the deaths of 70 children in Gambia from cough syrups in the Southeast Asian country as it investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.

India is testing samples of the cough syrups produced by Maiden Pharmaceuticals after the World Health Organisation said its products were linked to the deaths of dozens of children in the Gambia.

India will take "appropriate action" after completing an investigation into a complaint that a drug regulator helped switch samples of cough syrup linked to the death of children in Gambia in return for a bribe, two officials said on Wednesday.

Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or

Cough syrup from a Haryana-based firm that allegedly caused deaths of children in Gambia, has passed all tests, sources in Union Health Ministry told NDTV today.

A joint probe by the Centers for Disease Control and Prevention (CDC) of the US and the Gambian health authorities has suggested a strong link between the death of many children in Gambia and the consumption of made-in-India cough syrups that were al

Two pharmaceutical company executives have been sentenced to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia, reported Reuters.

Citing "unacceptable levels" of toxins in the products, the WHO is seeking information about the raw materials used by six manufacturers in India and Indonesia

The Centre today said it is in touch with Uzbekistan after it alleged 18 children in the country died after taking an Indian-made cough syrup. An investigation is in progress and the manufacturing of the cough syrup has been stopped.

Uzbekistan has claimed that at least 18 children in the country have died after allegedly taking an India-manufactured cough syrup.

Maiden Pharmaceuticals Ltd will seek clearance to re-open its factory after agovernment laboratory found nothing wrong in samples taken from syrups that the World Health Organisation (WHO) had suspected of being linked to children' deaths in Gambia

The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.

Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.

Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.

The committee to examine reports linking deaths of 66 children in The Gambia to four made-in-India cough syrups has observed the information shared by the World Health Organization is inadequate to determine aetiology.

Indonesia on Saturday banned ingredients linked to the deaths of 70 children in Gambia from cough syrups in the Southeast Asian country as it investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.

India is testing samples of the cough syrups produced by Maiden Pharmaceuticals after the World Health Organisation said its products were linked to the deaths of dozens of children in the Gambia.